Latest Cingulate Stock News | NASDAQ:CING | Benzinga

Benzinga

77349.001.1914%

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Benzinga Edge
Benzinga Pro
Benzinga Research
Benzinga APIs
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Events Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

77349.001.1914%

Cingulate Inc Stock News

CINGNASDAQ

Trade with Public

Trade with Public

$5.21

-0.005-0.1%

Last update: Sep 10, 11:12 AM

OverviewNewsEarnings Forecast Price Targets Financials Sentiment Ownership Compare Options Stock Report

Latest Cingulate Stock News | NASDAQ:CING | Benzinga

Get the latest news on Cingulate stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Cingulate performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Monday, August 24, 2026

PRO
Roth Capital Reiterates Buy on Cingulate, Low...
Benzinga Newsdesk

Thursday, August 20, 2026

PRO
Ascendiant Capital Maintains Buy on Cingulate...
Benzinga Newsdesk

Thursday, August 13, 2026

PRO
Cingulate Q2 EPS $(0.45) Beats $(0.63) Estima...
Benzinga Newsdesk

Tuesday, August 11, 2026

PRO
Cingulate Announces Publication Of CTx-1301 C...
Benzinga Newsdesk

Thursday, July 30, 2026

PRO
Cingulate Announces Phase 3 CTx-1301 ADHD Dat...
Benzinga Newsdesk

Thursday, July 02, 2026

PRO
Cingulate Joins Russell 3000E Index
Benzinga Newsdesk

Tuesday, June 16, 2026

PRO
Cingulate Receives U.S. Patent For ADHD Treat...
Benzinga Newsdesk

Tuesday, June 09, 2026

Apple To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Tuesday
Avi Kapoor

Monday, June 08, 2026

Oncology Institute To Rally Over 64%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
PRO
Ascendiant Capital Maintains Buy on Cingulate...
Benzinga Newsdesk

Wednesday, June 03, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights

Tuesday, June 02, 2026

PRO
Cingulate shares are trading higher after the...
Benzinga Newsdesk
PRO
Trading Halt: Halt status updated at 8:25:00 ...
Benzinga Newsdesk
PRO
Cingulate Receives FDA Complete Response Lett...
Benzinga Newsdesk
PRO
Trading Halt: Halted at 7:55:00 a.m. ET - Tra...
Benzinga Newsdesk

Tuesday, May 26, 2026

PRO
Cingulate shares are trading higher after HC ...
Benzinga Newsdesk
PRO
HC Wainwright & Co. Reiterates Buy on Cingula...
Benzinga Newsdesk

Thursday, May 14, 2026

PRO
Cingulate Q1 EPS $(0.95) Misses $(0.53) Estim...
Benzinga Newsdesk

Wednesday, April 22, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Wednesday, April 08, 2026

Amazon To Rally Around 22%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
PRO
Ascendiant Capital Maintains Buy on Cingulate...
Benzinga Newsdesk

Tuesday, March 24, 2026

PRO
Cingulate Files Prospectus Supplement Related...
Benzinga Newsdesk

Monday, March 23, 2026

PRO
Roth Capital Maintains Buy on Cingulate, Lowe...
Benzinga Newsdesk

Friday, March 20, 2026

What's Going On With Cingulate Stock Today?
Nabaparna Bhattacharya
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights

Wednesday, March 18, 2026

12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
PRO
Cingulate shares are trading lower after the ...
Benzinga Newsdesk
PRO
Cingulate Q4 EPS $(0.84) Misses $(0.61) Estim...
Benzinga Newsdesk

Thursday, January 22, 2026

12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga Insights

Monday, January 12, 2026

PRO
Cingulate Files For Mixed Shelf Offering Of U...
Benzinga Newsdesk

Monday, December 15, 2025

PRO
Cingulate CEO Shane Schaffer Reinstated Follo...
Benzinga Newsdesk

Monday, December 08, 2025

PRO
Ascendiant Capital Maintains Buy on Cingulate...
Benzinga Newsdesk

Wednesday, November 19, 2025

PRO
Roth Capital Maintains Buy on Cingulate, Lowe...
Benzinga Newsdesk

Tuesday, October 28, 2025

PRO
Cingulate Releases Phase 3 Trial Results For ...
Benzinga Newsdesk

Thursday, October 23, 2025

PRO
Cingulate's Data From Lead ADHD Candidate CTx...
Benzinga Newsdesk

Wednesday, October 15, 2025

PRO
Roth Capital Maintains Buy on Cingulate, Rais...
Benzinga Newsdesk

Tuesday, October 14, 2025

12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga Insights
PRO
Cingulate Announces That U.S. FDA Accepts For...
Benzinga Newsdesk

Wednesday, September 17, 2025

PRO
Cingulate Enters Commercial Supply Agreement ...
Benzinga Newsdesk

Friday, August 22, 2025

PRO
Ascendiant Capital Maintains Buy on Cingulate...
Benzinga Newsdesk

Tuesday, August 19, 2025

PRO
Cingulate Q2 EPS $(1.09) Misses $(0.84) Estim...
Benzinga Newsdesk

Friday, August 15, 2025

PRO
Cingulate Appoints Jennifer Callahan As Inter...
Benzinga Newsdesk

Friday, August 08, 2025

PRO
Cingulate Reports Termination Of EVP And COO ...
Benzinga Newsdesk

Wednesday, August 06, 2025

PRO
Cingulate Submits New Drug Application To FDA...
Benzinga Newsdesk

Tuesday, July 29, 2025

PRO
Cingulate Receives $4.3M Waiver From FDA For ...
Benzinga Newsdesk

Tuesday, July 22, 2025

PRO
Cing Cingulate Enters $25M Purchase Agreement...
Benzinga Newsdesk

Wednesday, June 18, 2025

12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights

Tuesday, May 27, 2025

PRO
Ascendiant Capital Maintains Buy on Cingulate...
Benzinga Newsdesk

Tuesday, May 20, 2025

PRO
Cingulate Announces Efficacy Results From Pha...
Benzinga Newsdesk

Monday, May 19, 2025

PRO
Roth Capital Maintains Buy on Cingulate, Lowe...
Benzinga Newsdesk

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Eli Lilly and Co

Johnson & Johnson

AstraZeneca PLC

Novo Nordisk AS

Bristol-Myers Squibb Co